ArisGlobal Revolutionizes Safety Signal Processing for Boehringer Ingelheim
May 3, 2024, 9:43 pm
LifeSphere Clarity redefines safety signal analysis for pharmaceutical giant Boehringer Ingelheim, setting a new standard in patient safety and risk management.
In the fast-paced world of pharmaceuticals, innovation is key. ArisGlobal, a leader in Life Sciences technology, has partnered with Boehringer Ingelheim to introduce LifeSphere Clarity, a game-changing solution that transforms safety signal processing.
Traditional signal detection is a thing of the past. LifeSphere Clarity goes beyond, offering access to knowledge graphs, association graphs, and medical case clustering. This advanced functionality allows for a deeper understanding of safety-relevant occurrences, leading to more efficient and standardized risk management for patient safety and pharmacovigilance teams.
Boehringer Ingelheim's patient safety teams initially developed an on-premise signal detection technology. ArisGlobal acquired this technology in 2023 and transformed it into LifeSphere Clarity, a cloud-based solution that adds value to the existing LifeSphere Signal & Risk Management platform.
With the ability to assess the downstream impact of safety signals more effectively, LifeSphere Clarity drives significant efficiency gains for healthcare organizations. As adverse event data becomes more complex, this innovative solution paves the way for enhanced safety monitoring and risk-benefit evaluation.
The future of the LifeSphere Signals ecosystem looks promising. Proactive Signal Detection and real-world data utilization are on the horizon, powered by LifeSphere NavaX, ArisGlobal's cognitive computing engine. These advancements will enable advanced AI and Generative AI functionality, further revolutionizing safety signal processing.
Dr. Robert Buchberger, Sr. VP of Patient Safety and Pharmacovigilance at Boehringer Ingelheim, expressed pride in the original signals innovation developed in-house. He highlighted the solution's industry-wide impact and its role in advancing safety data analytics to transform lives for generations.
Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal, emphasized the company's commitment to deploying cutting-edge technologies for the benefit of clients and patients. By collaborating closely with Boehringer Ingelheim on Clarity's development, ArisGlobal continues to meet the evolving needs of safety teams in a resource-intensive environment.
Boehringer Ingelheim, a research-driven biopharmaceutical company, is dedicated to creating breakthrough therapies that make a lasting impact. With a focus on innovation and sustainability, the company's mission aligns with ArisGlobal's goal of delivering advanced, efficient risk management solutions to expedite critical R&D processes and improve patient outcomes.
ArisGlobal's LifeSphere platform is at the forefront of global patient treatment technology, empowering life sciences companies to develop groundbreaking products and drive innovation. With a strong presence in the industry, ArisGlobal's commitment to excellence is evident in its partnerships and solutions that shape the future of healthcare.
In conclusion, the collaboration between ArisGlobal and Boehringer Ingelheim marks a significant milestone in safety signal processing. LifeSphere Clarity sets a new standard for efficiency, accuracy, and innovation in patient safety and risk management, paving the way for a brighter future in pharmaceuticals.
In the fast-paced world of pharmaceuticals, innovation is key. ArisGlobal, a leader in Life Sciences technology, has partnered with Boehringer Ingelheim to introduce LifeSphere Clarity, a game-changing solution that transforms safety signal processing.
Traditional signal detection is a thing of the past. LifeSphere Clarity goes beyond, offering access to knowledge graphs, association graphs, and medical case clustering. This advanced functionality allows for a deeper understanding of safety-relevant occurrences, leading to more efficient and standardized risk management for patient safety and pharmacovigilance teams.
Boehringer Ingelheim's patient safety teams initially developed an on-premise signal detection technology. ArisGlobal acquired this technology in 2023 and transformed it into LifeSphere Clarity, a cloud-based solution that adds value to the existing LifeSphere Signal & Risk Management platform.
With the ability to assess the downstream impact of safety signals more effectively, LifeSphere Clarity drives significant efficiency gains for healthcare organizations. As adverse event data becomes more complex, this innovative solution paves the way for enhanced safety monitoring and risk-benefit evaluation.
The future of the LifeSphere Signals ecosystem looks promising. Proactive Signal Detection and real-world data utilization are on the horizon, powered by LifeSphere NavaX, ArisGlobal's cognitive computing engine. These advancements will enable advanced AI and Generative AI functionality, further revolutionizing safety signal processing.
Dr. Robert Buchberger, Sr. VP of Patient Safety and Pharmacovigilance at Boehringer Ingelheim, expressed pride in the original signals innovation developed in-house. He highlighted the solution's industry-wide impact and its role in advancing safety data analytics to transform lives for generations.
Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal, emphasized the company's commitment to deploying cutting-edge technologies for the benefit of clients and patients. By collaborating closely with Boehringer Ingelheim on Clarity's development, ArisGlobal continues to meet the evolving needs of safety teams in a resource-intensive environment.
Boehringer Ingelheim, a research-driven biopharmaceutical company, is dedicated to creating breakthrough therapies that make a lasting impact. With a focus on innovation and sustainability, the company's mission aligns with ArisGlobal's goal of delivering advanced, efficient risk management solutions to expedite critical R&D processes and improve patient outcomes.
ArisGlobal's LifeSphere platform is at the forefront of global patient treatment technology, empowering life sciences companies to develop groundbreaking products and drive innovation. With a strong presence in the industry, ArisGlobal's commitment to excellence is evident in its partnerships and solutions that shape the future of healthcare.
In conclusion, the collaboration between ArisGlobal and Boehringer Ingelheim marks a significant milestone in safety signal processing. LifeSphere Clarity sets a new standard for efficiency, accuracy, and innovation in patient safety and risk management, paving the way for a brighter future in pharmaceuticals.